Bleeding After Cardiovascular Surgery: A Continuing Problem
- PMID: 39432577
- PMCID: PMC11495651
- DOI: 10.1161/CIRCULATIONAHA.124.071147
Bleeding After Cardiovascular Surgery: A Continuing Problem
Keywords: Editorials; antifibrinolytic agents; hemorrhage; thoracic surgery; tranexamic acid.
Conflict of interest statement
None.
Comment on
-
Topical Versus Intravenous Tranexamic Acid in Patients Undergoing Cardiac Surgery: The DEPOSITION Randomized Controlled Trial.Circulation. 2024 Oct 22;150(17):1315-1323. doi: 10.1161/CIRCULATIONAHA.124.069606. Epub 2024 Apr 8. Circulation. 2024. PMID: 38587333 Clinical Trial.
References
-
- Lamy A, Sirota D, Jacques F, Poostizadeh A, Noiseux N, Efremov S, Demers P, Akselrod B, Wang CY, Arara R, et al. Topical Versus Intravenous Tranexamic Acid in Patients Undergoing Cardiac Surgery: The DEPOSITION Randomized Controlled Trial. Circulation. 2024; in press - PubMed
-
- Ruel M, Chan V, Boodhwani M, McDonald B, Ni X, Gill G, Lam K, Hendry P, Masters R, Mesana T, How detrimental is reexploration for bleeding after cardiac surgery?, J Thorac Cardiovasc Surg. 2017; 154: 927–935. - PubMed
-
- Woodman RC, Harker LA. Bleeding Complications Associated With Cardiopulmonary Bypass. Blood. 1990; 76:1680–1697. - PubMed
-
- Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM, Bittl JA, Cohen MG, DiMaio JM, Don CW, et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145:e18–e114.: - PubMed
-
- Gill R, Herbertson M, Vuylsteke A, Olsen PS, von Heymann C, Mythen M, Sellke F, Booth F, Schmidt TA. Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery. Circulation. 2009;120:21–7. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources